E-LIB Suche - Ergebnisse für: Ruffin M

1

WS14.03 Combined therapeutic strategies for the restoration..:

Adam, D. ; Moustadraf, S. ; Orcese, B....
Journal of Cystic Fibrosis. 22 (2023) - p. S28 , 2023

Link: https://doi.org/10.1016/..

2

WS07.02 Lumacaftor/ivacaftor in people with cystic fibrosis..:

Mesinele, J. ; Ruffin, M. ; Guillot, L...
Journal of Cystic Fibrosis. 21 (2022) - p. S13 , 2022

Link: https://doi.org/10.1016/..

3

Gene Therapy: A Possible Alternative to CFTR Modulators?:

Mercier, J. ; Ruffin, M. ; Corvol, H..
Frontiers in Pharmacology. 12 (2021) - p. , 2021

Link: https://doi.org/10.3389/..

4

642: SLC6A14 is associated with lung function in patients w..:

Mercier, J. ; Calmel, C. ; Mésinèle, J....
Journal of Cystic Fibrosis. 20 (2021) - p. S305 , 2021

Link: https://doi.org/10.1016/..

5

Mise en place d'une consultation de l'immunodéprimé : résul..:

Redor, A. ; Sanhes, L. ; Ruffin, M...
Infectious Diseases Now. 51 (2021) 5 - p. S91 , 2021

Link: https://doi.org/10.1016/..

6

Prévention COVID-19 : du dépistage à la vaccination « hors ..:

Ruffin, M. ; Roy, M. ; Eden, A...
Infectious Diseases Now. 51 (2021) 5 - p. S137-S138 , 2021

Link: https://doi.org/10.1016/..

7

410: Pseudomonas aeruginosa modulates SARS-CoV-2 infectivit..:

Ruffin, M. ; Bigot, J. ; Calmel, C....
Journal of Cystic Fibrosis. 20 (2021) - p. S193 , 2021

Link: https://doi.org/10.1016/..

8

P048 Pseudomonas aeruginosa lung infection in paediatric cy..:

Mesinele, J. ; Ruffin, M. ; Guillot, L...
Journal of Cystic Fibrosis. 19 (2020) - p. S68 , 2020

Link: https://doi.org/10.1016/..

9

WS06.4 miR-9 and ANO1: Therapeutic targets in cystic fibros..:

Sonneville, F. ; Ruffin, M. ; Le Rouzic, P....
Journal of Cystic Fibrosis. 14 (2015) - p. S11 , 2015

Link: https://doi.org/10.1016/..

10

Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head..:

Colao, A. ; Bronstein, M. D. ; Freda, P....
The Journal of Clinical Endocrinology & Metabolism. 99 (2014) 3 - p. 791-799 , 2014

Link: https://doi.org/10.1210/..

11

Interprétation des résultats de surveillance individuelle d..:

Blanchin, N. ; Davesne, E. ; Chojnacki, E....
Radioprotection. 48 (2013) 3 - p. 411-430 , 2013

Link: https://doi.org/10.1051/..

12

WS15.4 Study of the chloride channel ANO1 in cystic fibrosi..:

Ruffin, M. ; Marie, S. ; Charlier, C....
Journal of Cystic Fibrosis. 11 (2012) - p. S33 , 2012

Link: https://doi.org/10.1016/..

13

Abnormal TRAF4 and TMEM16a expression during tracheal devel..:

Guillot, L. ; Ruffin, M. ; Riffault, L....
Journal of Cystic Fibrosis. 9 (2010) - p. S16 , 2010

Link: https://doi.org/10.1016/..

14

Modelling of bioassay data from a Pu wound treated by repea..:

Fritsch, P. ; Grappin, L. ; Guillermin, A. M....
Radiation Protection Dosimetry. 127 (2007) 1-4 - p. 120-124 , 2007

Link: https://doi.org/10.1093/..

15

Using open source software in product development: a primer:

Ruffin, M. ; Ebert, C.
IEEE Software. 21 (2004) 1 - p. 82-86 , 2004

Link: https://doi.org/10.1109/..